Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.40
GSK reports promising early results in ovarian and womb cancer drug trial
Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug GSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels,…
The Guardian
1 report1 sourceSimilarity 0.39
AI to predict how bowel cancer patients will respond to new NHS drug
PhenMap tool could spare thousands of patients from treatment that would be ineffective for them A new AI-driven way of identifying how patients with advanced bowel cancer will respond to a drug that was recently…
The Guardian
1 report1 sourceSimilarity 0.28
British minister says ‘disappointing’ no breakthrough in Iran war talks
He said US President Donald Trump’s earlier social media comments had been “incendiary”.
The Straits Times
3 reports3 sourcesSimilarity 0.25
Five killed in strikes on alleged drug boats in eastern Pacific, US military says
Attacks on Saturday bring number of people killed in boat strikes by US military to at least 168 The US military said that it blew up two boats accused of smuggling drugs in the eastern Pacific Ocean, killing a total… Grouped from 3 articles across 3 sources.
ABC Australia, CBS News, The Guardian
1 report1 sourceSimilarity 0.21
Merck's Keytruda: A lifesaving drug, a global divide
A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of the world's best selling drugs while leaving many patients struggling to access it.
DW
1 report1 sourceSimilarity 0.21
French cement maker convicted of financing terror groups to keep its Syria plant working
Lafarge fined more than €1m and its former boss jailed for paying nearly €5.6m to groups including Islamic State A French court has fined the cement group Lafarge more than €1m (£870,000) and sentenced its former boss…
The Guardian